Innoviva (INVA) SEC Filings & 10K Form

$14.93
-0.02 (-0.13%)
(As of 04/22/2024 ET)

Recent Innoviva SEC Filings

DateFilerForm TypeView
03/07/2024
5:57 PM
Innoviva (Issuer)
Raifeld Pavel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
6:00 PM
Innoviva (Issuer)
Zhen Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
6:02 PM
Innoviva (Issuer)
Ronsheim Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
6:04 PM
Basso Stephen (Reporting)
Innoviva (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Armata Pharmaceuticals, Inc. (Subject)
Innoviva (Filed by)
Form SC 13D/A
02/29/2024
4:01 PM
Innoviva (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
8:30 PM
Innoviva (Issuer)
Zhen Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
8:31 PM
Innoviva (Issuer)
Ronsheim Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:23 AM
Innoviva (Subject)
PUTNAM INVESTMENTS LLC (Filed by)
Form SC 13G/A
02/13/2024
9:26 AM
Innoviva (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
01/22/2024
8:16 PM
Innoviva (Issuer)
Ronsheim Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Innoviva (Subject)
Form SC 13G/A
01/10/2024
7:26 PM
Innoviva (Issuer)
Ronsheim Matthew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2023
3:30 PM
Innoviva (Issuer)
Zhen Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:30 PM
Innoviva (Issuer)
Zhen Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:30 AM
Innoviva (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
3:44 PM
Innoviva (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
3:30 PM
Innoviva (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
7:10 PM
Basso Stephen (Reporting)
Innoviva (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/31/2023
7:12 PM
Basso Stephen (Reporting)
Innoviva (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
4:24 PM
Innoviva (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
8:31 PM
Innoviva (Issuer)
Koziel Margaret (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2023
8:32 PM
Innoviva (Issuer)
Koziel Margaret (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
7:27 AM
Armata Pharmaceuticals, Inc. (Subject)
Innoviva (Filed by)
Form SC 13D/A
07/11/2023
7:16 AM
Innoviva (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
8:00 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
7:10 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
6:01 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:56 PM
Birx Deborah (Reporting)
Innoviva (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:57 PM
Innoviva (Issuer)
Srivastava Sapna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:47 PM
Innoviva (Issuer)
Odysseas Kostas D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:50 PM
DiPaolo Mark (Reporting)
Innoviva (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:53 PM
Haimovitz Jules (Reporting)
Innoviva (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:54 PM
Innoviva (Issuer)
Schlesinger Sarah J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
4:18 PM
Innoviva (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
3:30 PM
Innoviva (Issuer)
Zhen Marianne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
8:12 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4/A
05/19/2023
7:00 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
4:18 PM
Innoviva (Filer)
Form DEFA14A
05/15/2023
8:05 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/15/2023
8:09 PM
DENNER ALEXANDER J (Reporting)
Innoviva (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…
05/09/2023
4:21 PM
Innoviva (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INVA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners